Inhaled corticosteroids for the treatment of COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused severe illness and mortality for millions worldwide. Despite the development, approval and rollout of vaccination programmes globally to prevent infection by SARS-CoV-2 and the development of coronavirus disease 2019 (COVID-19), treatments are still urgently needed to improve outcomes. Early in the pandemic it was observed that patients with pre-existing asthma or COPD were underrepresented among those with COVID-19. Evidence from clinical studies indicates that the inhaled corticosteroids (ICS) routinely taken for asthma and COPD could have had a protective role in preventing severe COVID-19 and, therefore, may be a promising treatment for COVID-19. This review summarises the evidence supporting the beneficial effects of ICS on outcomes in patients with COVID-19 and explores the potential protective mechanisms.

Puedes leer el artículo completo en este enlace:

Noticias relacionadas con la COVID-19

Últimos 5 enlaces a artículos de COVID-19 en esta web:

Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría COVID en esta web.

También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.

Imagen obtenida del artículo original el 7.12.22

Entérate de
Nuestras Publicaciones